Phreesia Current Ratio 2019-2025 | PHR
Phreesia current ratio from 2019 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Phreesia Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-04-30 | $0.22B | $0.11B | 1.95 |
| 2025-01-31 | $0.20B | $0.11B | 1.78 |
| 2024-10-31 | $0.19B | $0.11B | 1.74 |
| 2024-07-31 | $0.18B | $0.10B | 1.77 |
| 2024-04-30 | $0.19B | $0.11B | 1.76 |
| 2024-01-31 | $0.20B | $0.11B | 1.78 |
| 2023-10-31 | $0.20B | $0.10B | 2.02 |
| 2023-07-31 | $0.22B | $0.09B | 2.58 |
| 2023-04-30 | $0.24B | $0.08B | 2.89 |
| 2023-01-31 | $0.26B | $0.08B | 3.32 |
| 2022-10-31 | $0.29B | $0.07B | 3.95 |
| 2022-07-31 | $0.32B | $0.07B | 4.40 |
| 2022-04-30 | $0.35B | $0.07B | 4.93 |
| 2022-01-31 | $0.39B | $0.07B | 5.65 |
| 2021-10-31 | $0.46B | $0.07B | 7.15 |
| 2021-07-31 | $0.49B | $0.06B | 8.56 |
| 2021-04-30 | $0.51B | $0.05B | 10.01 |
| 2021-01-31 | $0.27B | $0.06B | 4.95 |
| 2020-10-31 | $0.30B | $0.04B | 7.24 |
| 2020-07-31 | $0.13B | $0.04B | 3.36 |
| 2020-04-30 | $0.13B | $0.04B | 3.42 |
| 2020-01-31 | $0.13B | $0.04B | 3.72 |
| 2019-10-31 | $0.13B | $0.03B | 4.01 |
| 2019-07-31 | $0.14B | $0.04B | 3.52 |
| 2019-04-30 | $0.00B | 0.00 | |
| 2019-01-31 | $0.00B | 0.00 | |
| 2018-10-31 | $0.00B | 0.00 | |
| 2018-07-31 | $0.00B | 0.00 | |
| 2018-01-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.808B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.602B | 59.29 |
| Tempus AI (TEM) | United States | $13.186B | 0.00 |
| Doximity (DOCS) | United States | $12.437B | 55.33 |
| Hims & Hers Health (HIMS) | United States | $9.717B | 79.61 |
| IRhythm Technologies (IRTC) | United States | $5.323B | 0.00 |
| Hinge Health (HNGE) | United States | $4.319B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.748B | 40.40 |
| Privia Health (PRVA) | United States | $2.626B | 194.54 |
| Heartflow (HTFL) | $2.422B | 0.00 | |
| Enovis (ENOV) | United States | $1.771B | 9.36 |
| 10x Genomics (TXG) | United States | $1.752B | 0.00 |
| Omnicell (OMCL) | United States | $1.520B | 29.28 |
| Schrodinger (SDGR) | United States | $1.438B | 0.00 |
| Azenta (AZTA) | United States | $1.410B | 61.52 |
| Clover Health Investments (CLOV) | United States | $1.356B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.140B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.570B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.474B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 132.75 |
| Butterfly Network (BFLY) | United States | $0.390B | 0.00 |
| Carlsmed (CARL) | United States | $0.380B | 0.00 |
| TruBridge (TBRG) | United States | $0.298B | 52.29 |
| Outset Medical (OM) | United States | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.235B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.194B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 6.12 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.068B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |